India's Strategic Response to Monkeypox: Strengthening Public Health Infrastructure, Surveillance, and Global Collaboration for Future Zoonotic Threats
The recent global spread of monkeypox has underscored the critical need for robust public health strategies to combat zoonotic diseases. Historically confined to Central and West Africa, monkeypox has emerged as a significant threat to non-endemic regions, including India. This review examines India's comprehensive preparedness for monkeypox, highlighting the country's proactive measures in surveillance, healthcare infrastructure, public awareness, and international collaboration. The 2022 outbreak, marked by the West African clade, prompted heightened surveillance and targeted public health interventions, particularly among high-risk groups. In contrast, the 2024 outbreak, involving a more virulent strain, emphasized the importance of sustained vigilance and adaptive strategies. India’s response, focusing on early detection, equitable vaccine distribution, and strengthening healthcare infrastructure, has been critical in preventing widespread transmission. Moving forward, India's success will depend on continued investments in healthcare, effective public communication, and collaboration with global health organizations. By leveraging its role as a global leader in vaccine production and public health innovation, India is well-positioned to contribute to international efforts in combating zoonotic diseases and future health threats